[ Back to EurekAlert! ]

Contact: Phyllis Fisher
phyllis.fisher@gmail.com
212-606-1724
Hospital for Special Surgery

Lionel B. Ivashkiv, Hospital for Special Surgery

Caption: "We are very excited to try to understand how genes involved in lupus and rheumatoid arthritis are regulated, because it would represent a new way to drive therapy. It is called epigenetic therapy, meaning therapy targeted around how the environment controls gene expression and thus the environmental causes of disease," said Dr. Lionel B. Ivashkiv, director of the new center at Hospital for Special Surgery.

Credit: Robert Essel/Hospital for Special Surgery

Usage Restrictions: None

Related news release: New genomics center will study rheumatoid arthritis and lupus with $5.6 million grant


[ Back to EurekAlert! ]